Harrow, Inc. Investments and Other Noncurrent Assets
Harrow, Inc. (HROW) had Investments and Other Noncurrent Assets of $1.31 million as of 2020-12-31, per its 10-Q filed 2021-11-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:InvestmentsAndOtherNoncurrentAssets · last filed 2021-11-09
- 2020-12-31: Investments and Other Noncurrent Assets $1.31M.
| Period end | Investments and Other Noncurrent Assets |
|---|---|
| 2020-12-31 | $1.31M 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |